Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Varsinais-Suomen hyvinvointialue
Sponsor

Varsinais-Suomen hyvinvointialue

Finland Kiinamyllynkatu 4-8, 20520 Turku, Finland

About the sponsor

Research activity includes neonatal brain perfusion, cerebral elasticity, and early-life brain injury in newborns with hypoxic-ischemic, infectious, and ischemic conditions. The sponsor also studies maternal immunisation and the longer-term immune effects of pertussis vaccination in children.

  • Neonatal cerebral imaging
  • Brain perfusion assessment
  • Maternal and childhood pertussis immunity

These studies reflect interest in early diagnostic evaluation of the developing brain and in immune protection during pregnancy and early childhood.

About Specializations

Varsinais-Suomen hyvinvointialue runs clinical trials in conditions such as Multiple sclerosis, Pertussis immunisation, Rectal cancer, Metastases to lymph nodes, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

10 clinical trials

Rectal cancer+1

Recruiting

Study on the Use of Iron Oxide Nanoparticles in MRI to Detect Lymph Node Metastasis in Patients with Newly Diagnosed Rectal Cancer

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Sponsor:Varsinais-Suomen hyvinvointialue

Prostate cancer

Recruiting

Study on Estradiol and Exercise to Reduce Side Effects of Androgen Deprivation Therapy in Prostate Cancer Patients

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Estradiol
  • Sponsor:Varsinais-Suomen hyvinvointialue

Depression

Not yet recruiting

Effect of methohexital, propofol, and etomidate on electroconvulsive therapy outcomes in patients with severe depression

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Propofol
  • Sponsor:Varsinais-Suomen hyvinvointialue

Gastric cancer

Not yet recruiting

Diagnostic Accuracy of [18F]FAPI-74 PET/CT for Detecting Metastasis and Assessing Treatment Response in Gastric Cancer Patients

InvestigationalNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:[Al[18F]F]Fapi-74
  • Sponsor:Varsinais-Suomen hyvinvointialue

Multiple sclerosis+1

Not yet recruiting

A study testing hydroxychloroquine to reduce brain inflammation in patients with progressive multiple sclerosis

Registered drug
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Hydroxychloroquine Sulfate
  • Sponsor:Varsinais-Suomen hyvinvointialue

Colitis ulcerative+1

Not yet recruiting

Study on Fecal Microbiota Transplantation with Infliximab and Vedolizumab for Patients with Ulcerative Colitis

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:Varsinais-Suomen hyvinvointialue

Study on Newborn Brain Conditions Using Sulfur Hexafluoride Ultrasound for Babies with Hypoxic-Ischemic Injury, Stroke, or Infections

Not yet recruiting
Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years
  • Substances:Sulfur Hexafluoride
  • Sponsor:Varsinais-Suomen hyvinvointialue

Pertussis immunisation+2

Not recruiting

Study on the Effectiveness of dTap Vaccine in Boosting Immunity Against Diphtheria, Tetanus, and Whooping Cough in Healthcare Workers

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Diphtheria toxoid
  • Sponsor:Varsinais-Suomen hyvinvointialue

Pertussis immunisation

Not recruiting

Study of Long-term Pertussis Immunity in Children at Age 4 Years Following Maternal Vaccination During Pregnancy

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:0–17 years · 18–64 years · Healthy volunteers
  • Substances:Diphtheria toxoid adsorbed on aluminium hydroxide, hydrated
  • Sponsor:Varsinais-Suomen hyvinvointialue

Multiple sclerosis

Not recruiting

Study on the Effects of Cladribine on Brain Cells in Patients with Multiple Sclerosis

Registered drugNo placebo
Countries:FinlandFinland
  • Participants:18–64 years
  • Substances:Cladribine
  • Sponsor:Varsinais-Suomen hyvinvointialue

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.